DEF: Verano Holdings Corp. Announces Notice of Annual General Meeting of Shareholders

Verano Holdings Corp. will hold its 2025 annual general meeting of shareholders virtually on June 19, 2025, to discuss financial statements, elect directors, approve executive compensation, and re-appoint the auditor.

Summary

• Verano Holdings Corp. will hold its annual general meeting of shareholders on June 19, 2025, virtually.
• The meeting will address the company's financial statements for the year ended December 31, 2024, and the auditor's report.
• Shareholders will vote to set the number of directors at five and elect five director nominees.
• There will be a non-binding advisory vote on the compensation paid to the company's named executive officers.
• Macias Gini & O'Connell LLP will be considered for re-appointment as the company's auditor.
• The record date for determining shareholders eligible to vote is April 21, 2025.
• Shareholders can vote via the internet, mail, or proxy.
• The company is using notice-and-access to deliver proxy materials electronically, reducing printing and mailing costs.
• The company operates in 13 U.S. states with 155 retail dispensaries and 15 production facilities as of April 21, 2025.
• The company has a dual class authorized capital structure consisting of Subordinate Voting Shares and Proportionate Voting Shares.
• As of the Record Date, there are no Proportionate Voting Shares outstanding.

Sentiment

Score: 5

Explanation: The document presents a mix of positive and negative information. While the company is a leading player in the cannabis industry and has a strong retail presence, it also experienced a revenue decrease and a net loss. The sentiment is neutral overall.

Positives

• The company is using notice-and-access to reduce printing and mailing costs, which is environmentally friendly.
• The company has a Related Party Transaction Policy in place to manage potential conflicts of interest.
• The company has adopted a majority voting policy for director elections.
• The company has a clawback policy in place to recover incentive compensation in certain circumstances.
• The company has a stock ownership policy in place for executive officers to align their interests with those of shareholders.

Negatives

• The company's revenue decreased by 6% year-over-year.
• The company reported a net loss of $(342) million or (39)% of revenue.
• The company achieved financial performance below all Company financial targets set by the Committee, resulting in a 66.2% payout for the Company performance component for 2024 annual cash bonuses under the Annual Bonus Plan.

Risks

• The company operates in the cannabis industry, which is still illegal under U.S. federal law.
• The company's operations are subject to strict state and local regulations.
• The company's financial performance is subject to various risks, including competition, changing consumer preferences, and regulatory changes.

Future Outlook

The document does not provide a detailed future outlook, but it mentions the company's goal of ongoing development of communal wellness by providing responsible access to regulated medical and adult-use cannabis products.

Management Comments

• George Archos, Chair of the Board and Chief Executive Officer: 'By Order of the Board of Directors'
• George Archos, with the approval of the Committee, has chosen to forego his entire base salary for 2025.
• John Tipton, with the approval of the Board upon the recommendation of the Committee, has chosen to reduce his base salary to $400,000 for 2025.

Industry Context

The announcement highlights Verano's position as a leading company in the U.S. cannabis industry, operating in a sector with evolving regulations and ongoing federal illegality. The company's focus on both medical and adult-use cannabis reflects the broader trend of increasing legalization and market expansion within the industry.

Comparison to Industry Standards

• The document mentions Cresco Labs Inc., Curaleaf Holdings, Inc., Trulieve Cannabis Corp. and Green Thumb Industries Inc. as comparible companies.
• The document does not provide enough information to compare Verano's results to specific industry benchmarks or competitors in detail.
• The document does not provide enough information to compare Verano's projects to specific industry benchmarks or competitors in detail.

Management Changes

Related Party Transactions

• George Archos, the company's CEO, is a lender under the Credit Agreement.
• John Mitch Tipton, the immediate family member of John Tipton, a Director of the Company and the Company's President of the Southern Region, is employed by Plants of Ruskin prior to the Company acquiring Plants of Ruskin in the Go Public Transactions.
• The Company leases real property for a retail dispensary in Aurora, Illinois from 740 Rte. 59, LLC (740).
• The Company leases real property for a retail dispensary in Lombard, Illinois from 783 Butterfield LLC (783).

Stakeholder Impact

• Shareholders will have the opportunity to vote on key decisions affecting the company's governance and direction.
• Employees may be impacted by changes in executive compensation and company performance.
• Customers will continue to have access to the company's cannabis products and services.
• Suppliers and creditors may be affected by the company's financial performance and strategic decisions.

Next Steps

• Shareholders to vote on proposals at the annual general meeting on June 19, 2025.
• The Board to fix the auditor's remuneration and terms of engagement.
• The company to publish final voting results in a Current Report on Form 8-K.

Key Dates

Keywords

annual general meeting, shareholders, directors, executive compensation, auditor, proxy statement, cannabis, financial statements, voting, Verano Holdings